Loading ...

Emerson Sosa

Immune Tolerance Network

Clinical Operations Manager

Assessment Group

Allergy & Asthma

Type 1 Diabetes

esosa@immunetolerance.org

Work:

415-218-7981

Mobile:

Address:

Immune Tolerance Network

Committees:

,

Studies:

ITN070AD

-

ITN092AI

-

CD40L Antagonism in Rheumatoid Arthritis

ITN099AD

-

Abrocitinib Plus Peanut OIT Examining Combination Therapy

ITN101ST

-

EVR and EPO for Liver Transplant Tolerance

ITN830AI

-

DSG3-CAART for anti-DSG3 pemphigus vulgaris

ITN831AI

-

A Phase 2a Trial Of Teplizumab And RN168 In Patients With New Onset Type 1 Diabetes Mellitus

ITN832AI

-

Clinical phase II/III trial of Ustekinumab to treat type 1 diabetes.

ITN833AD

-

Bio:

Admin Links

Shortcuts

ITN Documents

Links